BRC Group Holdings and affiliated reporting persons acquired 460,080 BIOMERICA INC common shares, representing 10.03% of the class, for $736,128. The activist stake matters because the investors may pursue strategic transactions and BRPC can appoint a representative to Biomerica’s board, while B. Riley Securities will advise on evaluating potential deals.
Key Highlights
- The acquired common stock carries an aggregate purchase price of $736,128.
- B. Riley Principal Capital can appoint a representative to BIOMERICA INC’s board.
- B. Riley Securities received an exclusive advisory mandate with an initial term of 24 months.
BIOMERICA INC (NASDAQ: BMRA) now has BRC Group Holdings as a 10.03% activist Shareholder after the group acquired 460,080 common shares. The position is associated with BRC, B. Riley Principal Capital and Bryant R. Riley as reporting persons under a Schedule 13D.
Ownership Position Defined
The percentage is calculated against 4,588,968 outstanding common shares as of August 20, 2026. BIOMERICA INC’s common stock has a Par Value of $0.08 per share. BRC Group Holdings, B. Riley Principal Capital and Bryant R. Riley are each identified with a 10.03% beneficial ownership position. The ownership table lists 460,080 shares for each reporting person. A separate beneficial ownership description assigns 480,060 shares to BRC Group Holdings indirectly, B. Riley Principal Capital directly and Riley indirectly. B. Riley Principal Capital is described as a BRC Subsidiary whose principal Business is making investments, while BRC Group Holdings serves as a holding company. The reporting persons are described as having shared voting and disposition power over the common stock.
$736,128 Share Acquisition
The 460,080 purchased shares carried an aggregate price of $736,128. B. Riley Principal Capital used its Working Capital to acquire the shares directly. The purchases were made for Investment purposes and in the ordinary course of the reporting persons’ business. Their stated plans include buying, holding, voting, trading, selling or otherwise dealing in BIOMERICA INC common stock. The investors may assess changes in the stock’s market price, BIOMERICA INC’s operations, business strategy and prospects, as well as a potential sale or merger. Their review also covers management, business development, competitive and strategic matters, capital structure, market conditions and other investment considerations. The reporting persons may discuss those matters with BIOMERICA INC management or its board, other stockholders, industry analysts, potential strategic partners or competitors, financing professionals, Credit sources and other investors. Those discussions may lead to changes in ownership, information-sharing arrangements, proposals involving operations, governance or capitalization, or a transaction involving all or a controlling interest in BIOMERICA INC.
Board And Advisory Rights
B. Riley Principal Capital is entitled to appoint a representative to BIOMERICA INC’s board in connection with its Acquisition of the purchased shares. BIOMERICA INC also agreed to register the purchased shares under a registration rights agreement with B. Riley Principal Capital. At the transaction closing, BIOMERICA INC entered into an engagement letter with B. Riley Securities, an affiliate of BRC Group Holdings and B. Riley Principal Capital. The reporting persons also reserve the right to develop other plans, acquire more common stock or dispose of some or all of their holdings through open-market or privately negotiated transactions.
Peers Moving on This News
- Autonomix Medical, Inc. (NASDAQ: AMIX) down 3.9%
- ENvue Medical, Inc. (NASDAQ: FEED) up 0.5%




Please wait processing your request...